Antiviral drug synergy and mutational signatures in different epithelial cell models of RSV and hPIV infection
Samuel Ellis, Amy I. Jacobs, Shengyuan Zhang, Laura Buggiotti, Maximillian N. J. Woodall, Jila Ajeian, Helena J. Tutill, Charles M. Miller, Macheala Palor, Angelika Kopec, Elizabeth K. Haughey, Hongxia Ma, Mia Tomlinson, Rachel J. Williams, Christopher O’Callaghan, , Judith Breuer
This study evaluates antiviral drug synergy and mutational signatures of RdRp inhibitors against RSV and hPIV in epithelial cell models and primary airway cultures.
bioRxiv · Jan 13, 2026 · PreprintMicrobiology